ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,064.59
      1.08%
      US Tech 100
      16,938.00
      1.11%
      Dow Jones
      38,430.95
      0.50%
      Brent Oil
      86.325
      -0.10%
      Bitcoin
      67,140.92
      0.42%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Galectin Therapeutics Inc (GALT)

      7. Galectin Therapeutics Inc (GALT) News

      GALT Galectin Therapeutics Inc

      3.16
      0.10 (3.27%)
      Last Updated: 10:21:05
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Galectin Therapeutics Inc GALT NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.10 3.27% 3.16 10:21:05
      Open Price Low Price High Price Close Price Prev Close
      2.99 2.99 3.17 3.06
      more quote information »

      Recent News

      Date Time Source Heading
      3/04/202412:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202416:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202416:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202416:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202416:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202416:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202416:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202416:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202416:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/16/202411:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/02/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/18/202308:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/11/202316:15EDGAR2Form 8-K - Current report
      12/07/202311:42EDGAR2Form 8-K - Current report
      12/01/202316:50EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
      12/01/202316:38EDGAR2Form SC 13D/A - General statement of acquisition of..
      12/01/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/15/202317:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/13/202309:21EDGAR2Form 8-K/A - Current report: [Amend]
      11/13/202308:45GLOBEUPDATE – Galectin Therapeutics Reports Financial Results for..
      11/13/202308:00GLOBEGalectin Therapeutics Reports Financial Results for the..
      11/13/202307:55EDGAR2Form 8-K - Current report
      11/13/202307:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/03/202308:00GLOBEGalectin Therapeutics to Share Five Scientific Presentations..
      10/31/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/23/202308:00GLOBEGalectin Therapeutics to Participate in the H.C. Wainwright..
      10/16/202308:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/12/202308:00GLOBEGalectin Therapeutics Announces Nomination of Dr. Benjamin..
      10/06/202308:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      10/06/202308:03EDGAR2Form DEF 14A - Other definitive proxy statements
      10/03/202308:00GLOBEGalectin Therapeutics Reports the Positive Outcome of the..
      10/02/202307:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/27/202314:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202308:00GLOBEGalectin Therapeutics to Present Update on its Belapectin..
      9/18/202309:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/11/202316:38EDGAR2Form 144 - Report of proposed sale of securities
      9/11/202308:00GLOBEGalectin Therapeutics to Participate in the H.C. Wainwright..
      9/07/202312:00GLOBEGalectin Therapeutics to Present Data on Liver Cirrhosis at..
      9/01/202307:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/15/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202308:00GLOBEGalectin Therapeutics Reports Financial Results for the..
      8/14/202307:55EDGAR2Form 8-K - Current report
      8/14/202307:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      7/31/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/20/202307:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/17/202308:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/03/202307:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      GALT
      Galectin Therapeutics
      Delayed Upgrade Clock